Author/Creator: Suresh, Sumanth C. - British Library Electronic Legal Deposit Catalogue-Journal Issues and Articles Search Results

Author/Creator Suresh, Sumanth C.

1. Reply to the letter "thioredoxin-1 (Trx1) engineered mesenchymal stem cell therapy is a promising feasible therapeutic approach for myocardial infarction". (15th March 2016)

Authors:: Maulik, Nilanjana; Thirunavukkarasu, Mahesh; Selvaraju, Vaithinathan; Suresh, Sumanth C.
Journal:: International journal of cardiology
Issue:: Volume 207(2016)
Page Start:: 277
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

2. Thioredoxin-1 (Trx1) engineered mesenchymal stem cell therapy increased pro-angiogenic factors, reduced fibrosis and improved heart function in the infarcted rat myocardium. (15th December 2015)

Authors:: Suresh, Sumanth C.; Selvaraju, Vaithinathan; Thirunavukkarasu, Mahesh; Goldman, Joshua W.; Husain, Aaftab; Alexander Palesty, J.; Sanchez, Juan A.; McFadden, David W.; Maulik, Nilanjana
Journal:: International journal of cardiology
Issue:: Volume 201(2015)
Page Start:: 517
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗